Lipid Controls
Indofine Chemical 1-Monocaprin, 99%, 50 Mg
1-MONOCAPRIN 50 MG, Lipid Research, 1-Monodecanoin, 99%, 2277-23-8, MFCD00056656
Avanti Polar Lipids TOPFLUOR CHOLESTEROL, 1MG
23-(dipyrrometheneboron difluoride)-24-norcholesterol (TopFluor Cholesterol). 878557-19-8
Echelon Biosciences Research Labs PC/PS LIPID MICROPARTICL 100UL
PC/PS Lipid Microparticles contain attached phosphatidylcholine and phosphatidylserine with the phospholipid headgroups exposed and available for biological interactions. Phosphatidylserine (PS) is an anionic, intracellular phospholipid component of the cell membrane and is involved in cell signaling including apoptosis. Phosphatidylcholine (PC) is primarily an extracellular phospholipid component of cell membranes and is a key structural lipid. This item is non returnable
Medchemexpress LLC HY-145405 50mg , C12-200 CAS:1220890-25-4 Purity:>98%
HY-145405 50mg C12-200 CAS: 1220890-25-4 C12-200 is a benchmark ionizable cationic lipidoid along with helper lipids. C12-200 is commonly used for mRNA delivery. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Avanti Polar Lipids 18:1 Lyso PC, 19420-56-5, MFCD00133435, powder, 25mg
Molecular Formula C26H52NO7P, Purity >99% LPC; may contain up to 10% of the 2-LPC isomer, Formula Weight 521.667, Synonyms: 1-oleoyl-2-hydroxy-sn-glycero-3-phosphocholine
Avanti Polar Lipids 1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt), 104872-42-6, MFCD00145456, 200mg
Molecular Formula: C42H84ClNO2, Formula Weight: 670.575, Purity >99%.
STEMCELL Technologies Lipopolysaccharide from E. col
Lipopolysaccharide extracted from E. coli (wild-type S-form serotype O55:B5)
Avanti Polar Lipids 1,2-DIDOCOSAHEXAENOYL-SN-GLYCE
1,2-didocosahexaenoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) 25mg
Cayman Chemical DLIn-MC3-DMA 100mg
An ionizable cationic lipid (apparent pKa = 6.44); has been used in the generation of lipid nanoparticles (LNPs) encapsulating siRNA, mRNA, or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-MC3-DMA accumulate in the muscle and non-draining lymph nodes after intramuscular administration and in the spleen after intravenous administration in mice; LNPs containing DLin-MC3-DMA and encapsulating F7 siRNA reduce hepatic and plasma Factor VII levels in mice without inducing liver toxicity